CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Pirfenidone

Last Updated: August 29, 2014
Result type: Reports
Project Number: SR0393
Product Line: Common Drug Review

Generic Name: Pirfenidone

Brand Name: Esbriet

Manufacturer: Hoffmann-La Roche Ltd.

Indications: Pulmonary fibrosis (idiopathic, mild to moderate)

Submission Type: Resubmission

Project Status: Complete

Date Recommendation Issued: April 15, 2015

Recommendation Type: List with criteria/condition